1. Home
  2. DK vs VKTX Comparison

DK vs VKTX Comparison

Compare DK & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

N/A

Current Price

$74.25

Market Cap

3.4B

Sector

Energy

ML Signal

N/A

VKTX

Viking Therapeutics Inc.

N/A

Current Price

$28.49

Market Cap

4.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DK
VKTX
Founded
2001
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
4.0B
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
DK
VKTX
Price
$74.25
$28.49
Analyst Decision
Buy
Strong Buy
Analyst Count
13
20
Target Price
$76.77
★ $94.71
AVG Volume (30 Days)
2.0M
★ 7.6M
Earning Date
11-06-2026
10-21-2026
Dividend Yield
★ 1.33%
N/A
EPS Growth
★ 95.67
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$33.50
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.85
$25.77
52 Week High
$82.27
$43.15

Technical Indicators

Market Signals
Indicator
DK
VKTX
Relative Strength Index (RSI) 53.70 40.20
Support Level $61.60 N/A
Resistance Level $77.40 $35.23
Average True Range (ATR) 3.37 2.25
MACD 0.12 -0.58
Stochastic Oscillator 74.61 8.97

Price Performance

Historical Comparison
DK
VKTX

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has three segments: Refining segment and Logistics segment and retail segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: